封面
市場調查報告書
商品編碼
1629614

乳酸林格注射劑市場:按配方、按容量、按年齡層、按容器、按分銷管道、按地區

Lactated Ringers Injection Market, By Formulation, By Volume, By Age Group, By Container, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年,全球乳酸林格注射劑市場預計為5.101億美元,預計到2031年將達到7.622億美元,2024年至2031年的複合年成長率為5.9%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 5.101 億美元
實際資料 2019年至2023年 預測期 從2024年到2031年
預測 2024-2031 年複合年成長率: 5.90% 2031年價值預測 7.622 億美元
圖:2024 年按地區分類的乳酸林格氏市場佔有率(%)
乳酸林格注射劑市場-IMG1

乳酸林格注射是最常用的靜脈注射液之一,用於恢復體液和控制脫水。有助於恢復體內電解質平衡和液體量。近年來,由於需要輸注治療的慢性疾病和損傷的盛行率不斷上升,全球乳酸林格注射液市場一直穩定成長。此外,人口老化的加劇,容易出現電解質失衡,也導致乳酸林格注射液的需求增加。由於全球意識的提高和醫療保健設施的改善,預計市場在預測期內將保持良好的前景。

市場動態:

由於糖尿病、心血管疾病和腎臟疾病等經常導致電解質失衡的慢性疾病的盛行率不斷上升,全球乳酸林格注射劑市場正在穩步成長。此外,道路事故、傷害和創傷的風險不斷增加,以及需要緊急液體復甦的病例數量不斷增加,進一步推動了市場的成長。此外,人口老化的加劇,更容易出現電解質紊亂,對乳酸林格注射液的維持需求也很高。然而,有關輸液核准的嚴格規定可能會阻礙市場成長。此外,替代靜脈注射治療產品的可用性也是一個限制因素。同時,新興國家不斷增加的醫療保健投資為市場進入者提供了重大機會。

本研究的主要特點

本報告對全球乳酸林格注射劑市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。

它揭示了各個細分市場的潛在商機,並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、業績和策略等參數,介紹了全球乳酸林格注射劑市場的主要企業。

主要公司有 Baxter International Inc.、B. Braun Melsungen AG、ICU Medical, Inc.、Fresenius Kabi AG、Hospira, Inc.、Otsuka Pharmaceutical Co., Ltd.、Dechra Pharmaceuticals PLC、Vedco, Inc.、Grifols SA 、輝瑞公司、安進公司、Eton Pharmaceuticals, Inc.、Sagent Pharmaceuticals, Inc. 和Aurobindo Pharma Limited。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球乳酸林格注射劑市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球乳酸林格注射劑市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要進展
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業動態

第4章2019-2031年全球乳酸林格注射劑市場(依配方)

  • 標準乳酸林格氏液
  • 含添加劑(葡萄糖、氯化鈉等)的乳酸林格氏液

第5章全球乳酸林格注射劑市場,依產能分類,2019-2031

  • 250ml
  • 500mL
  • 1,000ml

第6章全球乳酸林格注射劑市場,依年齡層別,2019-2031

  • 成人
  • 兒科的
  • 老年人

第7章2019-2031年全球乳酸林格注射劑市場(依貨櫃)

  • 塑膠瓶
  • PVC袋
  • 玻璃瓶、小瓶等

第8章2019-2031年全球乳酸林格注射劑市場(依通路)

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章2019-2031年全球乳酸林格注射劑市場(按地區)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章競爭格局

  • Baxter International Inc.
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols SA
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

第11章分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第12章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI7567

The global lactated ringers injection market is estimated to be valued at USD 510.1 Mn in 2024 and is expected to reach USD 762.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 510.1 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.90% 2031 Value Projection: US$ 762.2 Mn
Figure. Lactated Ringers Injection Market Share (%), By Region 2024
Lactated Ringers Injection Market - IMG1

Lactated ringers injection is one of the most commonly prescribed intravenous fluids used for fluid resuscitation and management of dehydration. It helps restore electrolyte balance and fluid volume in the body. The global lactated ringers injection market has been witnessing steady growth in the recent past due to the rising prevalence of chronic diseases and injuries that require intravenous therapy. Furthermore, the growing geriatric population who are more prone to electrolyte imbalance is also contributing to the increased demand for lactated ringers injection. With growing awareness and improved access to healthcare facilities globally, the market is expected to continue its positive outlook over the forecast period.

Market Dynamics:

The global lactated ringers injection market has been experiencing steady growth attributed to the rising prevalence of chronic health conditions such as diabetes, cardiovascular diseases, and kidney ailments that often lead to electrolyte imbalance. Additionally, the growing risk of road accidents, injuries, and trauma cases requiring emergency fluid resuscitation are further propelling market growth. Furthermore, the growing geriatric population who are more susceptible to electrolyte disorders is creating high maintenance demand for lactated ringers injection. However, stringent regulations pertaining to intravenous fluid approvals may hinder market growth. Moreover, the availability of alternative IV therapy products acts as a restraint. On the other hand, increasing healthcare investments in emerging nations provide significant opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global lactated ringers injection market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global lactated ringers injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius Kabi AG, Hospira, Inc., Otsuka Pharmaceutical Co., Ltd., Dechra Pharmaceuticals PLC, Vedco, Inc., Grifols S.A., Pfizer Inc., Amgen Inc., Eton Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., and Aurobindo Pharma Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global lactated ringers injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lactated ringers injection market

Market Segmentation

  • By Formulation Insights (Revenue, USD Mn, 2019 - 2031)
    • Standard Lactated Ringer's Solution
    • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
  • By Volume Insights (Revenue, USD Mn, 2019 - 2031)
    • 250 ml
    • 500 ml
    • 1,000 ml
  • By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
    • Adults
    • Pediatrics
    • Geriatrics
  • By Container Insights (Revenue, USD Mn, 2019 - 2031)
    • Plastic Bottles
    • PVC Bags
    • Glass Bottles/Vials etc.
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Baxter International Inc.
    • Braun Melsungen AG
    • ICU Medical, Inc.
    • Fresenius Kabi AG
    • Hospira, Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • Dechra Pharmaceuticals PLC
    • Vedco, Inc.
    • Grifols S.A.
    • Pfizer Inc.
    • Amgen Inc.
    • Eton Pharmaceuticals, Inc.
    • Sagent Pharmaceuticals, Inc.
    • Aurobindo Pharma Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lactated Ringers Injection Market, By Formulation
    • Global Lactated Ringers Injection Market, By Volume
    • Global Lactated Ringers Injection Market, By Age Group
    • Global Lactated Ringers Injection Market, By Container
    • Global Lactated Ringers Injection Market, By Distribution Channel
    • Global Lactated Ringers Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lactated Ringers Injection Market, By Formulation, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Standard Lactated Ringer's Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Lactated Ringer's with Additives (Dextrose, sodium chloride, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Lactated Ringers Injection Market, By Volume, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • 250 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 500 mL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • 1,000 ml
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Lactated Ringers Injection Market, By Age Group, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Lactated Ringers Injection Market, By Container, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Plastic Bottles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • PVC Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Glass Bottles/Vials etc.
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Lactated Ringers Injection Market, By Distribution Channel, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Lactated Ringers Injection Market, By Region, 2019 - 2031, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Formulation, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Volume, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Container, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ICU Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hospira, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
  • Vedco, Inc.
  • Grifols S.A.
  • Pfizer Inc.
  • Amgen Inc.
  • Eton Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us